Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128860) titled 'Multimodal magnetic resonance hypoxia imaging combined with AI temporal analysis to construct a warning system for resistance to targeted-immunotherapy combination treatment and an individualized intervention system for unresectable hepatocellular carcinoma' on July 27.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Guabgzhou First People's Hospital
Condition:
Hepatocellular carcinoma
Intervention:
Modeling Exploration Group:None
External Validation Group:None
Conventional Treatment Group:Targeted - Immunotherapy Combination Therapy + RECIST 1.1 Standard Adjustment Plan
Recruitmen...